Through an extensive literature review, we compiled multiple datasets related to glioma chemotherapy, which indicated significant differences in TMED9 expression when compared to a control group, including patients receiving first-line glioma treatment drugs such as temozolomide, disulfiram, and JQ1 (Figures 10C–F). The gene discussed is TMED9; the disease is central nervous system cancer.